Relation of Blood-boron Levels With Body Mass Index

July 21, 2011 updated by: SB Istanbul Education and Research Hospital

Phase 1 Study of Blood Boron Levels According to Body Mas Index

According to our experimental experiences w hypothesized that blood boron levels may be corralated to body mass index.

Study Overview

Status

Unknown

Conditions

Detailed Description

In the results of our experimental study on mices we revealed that low dose oral boric acid intake cause seriously body mas reducing. Although blood and urine analyses support high glucose, lipid and middle protein catabolisms, but the mechanism was unclear. There are some diseases according to blood elementary deficiencies, like hypothyroidi in hypoiyodinemia, hiperparathyroidi in hypocalcemia, etc. We hypothesised that hypoboronemia may be corralated to body mass index level.

Study Type

Observational

Enrollment (Anticipated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: erhan aysan, assoc. prof.
  • Phone Number: +902124531700

Study Contact Backup

  • Name: gokhan cipe, MD
  • Phone Number: +902124531700

Study Locations

  • Turkey
      • Istanbul, Turkey, 34543
        • Bezmialem Vakif University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Normal: 19-24 Overweight: 25-29 Obes: 30-40 Morbid Obes: >40

Description

Inclusion Criteria:

  • body mas index levels in over 19 peoples

Exclusion Criteria:

  • known chronic, morbid and malign diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
normal
body mass index: 19-24
overweight
body mass index: 25-29
obesity
body mass index: 30-40
modbid obes
body mass index: over 40

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood boron level
Time Frame: 6 months
blood boron levels will be measured cantitatively
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
body mass index
Time Frame: 6 months
body mass index levels will be evaluated with blood boron levels
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

SB Istanbul Education and Research Hospital

Investigators

  • Study Chair: adnan yuksel, prof, rector

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2011

Primary Completion (Anticipated)

October 1, 2011

Study Completion (Anticipated)

December 1, 2011

Study Registration Dates

First Submitted

July 21, 2011

First Submitted That Met QC Criteria

July 21, 2011

First Posted (Estimate)

July 22, 2011

Study Record Updates

Last Update Posted (Estimate)

July 22, 2011

Last Update Submitted That Met QC Criteria

July 21, 2011

Last Verified

July 1, 2011

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • bor1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe